Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Aging Biology|May 13, 2024
An Enterobacteriaceae bloom in aging animals is restrained by the gut microbiomeRebecca Choi, Rahul Bodkhe, Barbara Pees, et al.The ISME Journal|January 16, 2021
Host population diversity as a driver of viral infection cycle in wild populations of green sulfur bacteria with long standing virus-host interactionsMaureen Berg, Danielle Goudeau, Charles Olmsted, et al.Applied and Environmental Microbiology|June 20, 2025
Cryptic cycling by electroactive bacterioplankton in Trout Bog LakeCharles N Olmsted, Mark Gahler, Eric Roden, et al.Gynecologic Oncology|February 14, 2025
A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancerStéphanie Gaillard, Neha Verma, Maureen Berg, et al.Msystems|July 8, 2025
Tetranucleotide frequencies differentiate genomic boundaries and metabolic strategies across environmental microbiomesMatthew Kellom, Maureen Berg, I-Min A Chen, et al.Microbiome|August 11, 2020
Influence of the polar light cycle on seasonal dynamics of an Antarctic lake microbial communityPratibha Panwar, Michelle A Allen, Timothy J Williams, et al.Cancer Immunology Research|August 14, 2014
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancerGang Chen, Richa Gupta, Silvia Petrik, et al.Nature Communications|June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.Nature Communications|July 23, 2026
Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trialEric S Christenson, Jeremiah A Wala, Rose Parkinson, et al.Cancer Discovery|July 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohortsS Daniel Haldar, Amanda L Huff, Hejia Henry Wang, et al.Pageof 3